FDA Approves First Generics of Heart Failure Combo Drug Entresto

The FDA has approved the first generics of Entresto® tablets. The combination of sacubitril and valsartan is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure.
[Medical Professionals Reference]
Press Release